ANKE BIO(SZ:300009) Xin Lang Zheng Quan·2025-12-03 05:41Core Viewpoint - Anke Biological has experienced a decline in stock price recently, with a year-to-date increase of 15% but a notable drop in the last 20 and 60 days [1][2] Financial Performance - For the period from January to September 2025, Anke Biological reported a revenue of 1.963 billion yuan, representing a year-on-year growth of 2.15%. However, the net profit attributable to shareholders decreased by 6.48% to 551 million yuan [2] - The company has distributed a total of 2.662 billion yuan in dividends since its A-share listing, with 1.252 billion yuan distributed in the last three years [3] Stock Market Activity - As of December 3, Anke Biological's stock price was 9.65 yuan per share, with a market capitalization of 16.14 billion yuan. The stock has seen a trading volume of 155 million yuan and a turnover rate of 1.31% [1] - The stock has been on the "龙虎榜" (a list of stocks with significant trading activity) once this year, with a net purchase of 193 million yuan on July 31 [1] Shareholder Information - As of November 10, the number of shareholders for Anke Biological was 76,100, a decrease of 1.10% from the previous period. The average number of circulating shares per shareholder increased by 1.11% to 16,062 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and several investment funds, with notable changes in their holdings [3]